Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Research article

Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study

Authors: Debbie Cavers, Rhona Duff, Annemieke Bikker, Karen Barnett, Lovney Kanguru, David Weller, David H. Brewster, Christine Campbell

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

More people are surviving a first primary cancer and experiencing a second, different cancer. However, little is known about the diagnostic journeys of patients with second primary cancer (SPC). This study explores the views of patients and general practitioners (GPs) on their experiences of pathways to diagnosis of SPC, including the influence of a previous diagnosis of cancer on symptom appraisal, help-seeking and referral decisions.

Methods

Qualitative interviews with patients with a SPC diagnosis and case-linked GP interviews in a Scottish primary care setting. In-depth face to face or telephone interviews were conducted, underpinned by a social constructionist approach. Interviews were transcribed and Braun and Clarke’s thematic analysis undertaken. Three analysts from the research team read transcripts and developed the coding framework using QSR NVivo version 10, with input from a fourth researcher. Themes were developed from refined codes and interpreted in the context of existing literature and theory.

Results

Interviews were conducted with 23 patients (aged 43–84 years) with a SPC diagnosis, and 7 GPs. Five patient themes were identified: Awareness of SPC, symptom appraisal and help-seeking, pathways to diagnosis, navigating the healthcare system, and impact of SPC. GPs interviews identified: experience and knowledge of SPC and referrals and decision-making.

Conclusions

Insights into the pathway to diagnosis of SPC highlights the need for increased awareness of and vigilance for SPC among patients and healthcare providers (HCPs), and emotional support to manage the psychosocial burden.
Appendix
Available only for authorised users
Literature
3.
8.
go back to reference Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC Cancer. 2011;11:83. Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC Cancer. 2011;11:83.
10.
13.
go back to reference Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda: National Cancer Institute; 2003. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda: National Cancer Institute; 2003.
19.
29.
go back to reference Scheel BI, Ingebrigtsen ST, Thorsen T, Holtedahl K. Cancer suspicion in general practice: the role of symptoms and patient characteristics, and their association with subsequent cancer. Br J Gen Pract. 2013;63(614):e627–35. https://doi.org/10.3399/bjgp13X671614. Scheel BI, Ingebrigtsen ST, Thorsen T, Holtedahl K. Cancer suspicion in general practice: the role of symptoms and patient characteristics, and their association with subsequent cancer. Br J Gen Pract. 2013;63(614):e627–35. https://​doi.​org/​10.​3399/​bjgp13X671614.
32.
go back to reference Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353–65. https://doi.org/10.1016/S1470-2045(12)70041-4. Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353–65. https://​doi.​org/​10.​1016/​S1470-2045(12)70041-4.
33.
go back to reference Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(Suppl. 1):S92–S107. https://doi.org/10.1038/bjc.2015.48. Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(Suppl. 1):S92–S107. https://​doi.​org/​10.​1038/​bjc.​2015.​48.
38.
go back to reference Kummer S, Walter F, Chilcot J, Emery J, Sutton S, Scott S. Do cognitive heuristics underpin symptom appraisal for symptoms of cancer?: a secondary qualitative analysis across seven cancers. Psycho-oncology. 2019. https://doi.org/10.1002/pon.5049. Kummer S, Walter F, Chilcot J, Emery J, Sutton S, Scott S. Do cognitive heuristics underpin symptom appraisal for symptoms of cancer?: a secondary qualitative analysis across seven cancers. Psycho-oncology. 2019. https://​doi.​org/​10.​1002/​pon.​5049.
Metadata
Title
Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study
Authors
Debbie Cavers
Rhona Duff
Annemieke Bikker
Karen Barnett
Lovney Kanguru
David Weller
David H. Brewster
Christine Campbell
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08238-0

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine